Hillstream BioPharma, Inc. (HILS)

NASDAQ: HILS · Delayed Price · USD
3.76
0.40 (11.90%)
At close: Jan 24, 2022 4:00 PM
3.61
-0.15 (-3.99%)
Pre-market:Jan 25, 2022 8:01 AM EST
Market Cap42.23M
Revenue (ttm)n/a
Net Income (ttm)-5.52M
Shares Out11.23M
EPS (ttm)-0.49
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,149,133
Open3.21
Previous Close3.36
Day's Range3.21 - 3.95
52-Week Range2.52 - 4.17
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About HILS

Hillstream BioPharma is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (“IMCD”) for treatment resistant cancers. Our most advanced product candidate is HSB-1216, an IMCD inducer, targeting a variety of solid tumors. In a clinical pilot study conducted in Germany by the University of Heidelberg, the active drug in HSB-1216 was found to reduce tumor burden in treatment resistant cancers, including triple negative br...

IndustryBiotechnology
IPO DateJan 12, 2022
CEORandy Milby
Employees1
Stock ExchangeNASDAQ
Ticker SymbolHILS
Full Company Profile

Financial Performance

Financial Statements

News

4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy?

Thanks to continued fear and uncertainty, the stock market is down again… The post 4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News...

Other symbols:ARDSGMVDSBEV
21 hours ago - PennyStocks

The Stock Market is Down Today: Here's Why & 3 Penny Stocks To Watch

Here's why the stock market is down today & 3 penny stocks going against the trend. The post The Stock Market is Down Today: Here's Why & 3 Penny Stocks To Watch appeared first on Penny Stocks to Buy, P...

Other symbols:HEPSPT
3 days ago - PennyStocks

Hillstream BioPharma Announces Closing of Initial Public Offering

BRIDGEWATER, NJ / ACCESSWIRE / January 14, 2022 / Hillstream BioPharma, Inc. (NASDAQ:HILS) ("Hillstream", the "Company"), a biotechnology company developing novel therapeutic candidates targeting ferrop...

1 week ago - Accesswire